Statins may protect against breast cancer treatment side-effectsWith cardiovascular disease being a leading cause of death among elderly early breast cancer survivors, there is motivation to reduce the risk of cardiotoxicity. Statins have emerged as a promising candidate. Should COVID-19 vaccine be given to patients taking oral anticoagulants?Thrombosis Canada issues statement covering warfarin, DOACs and antiplatelet agents. Epidural anesthesia reduces mortality in leg revascularization surgery Lipid-lowering therapy beneficial for patients older than 75 years Two studies show LDL lowering significantly reduces the risk of major vascular events in older patients. Canadian atrial fibrillation guidelines completely updated for 2020 Designed to help improve clinical management of an important and challenging arrhythmia. Risk of cardiovascular events with SGLT2 inhibitors versus DPP-4 inhibitors Canadian researchers compare the “real world” risk of cardiovascular events with SGLT2 inhibitors and DPP-4 inhibitors in type 2 diabetes. Better hypertension management: How to work with patients for improved BP results How to work with patients for improved blood pressure results New Canadian statement on management of pulmonary hypertension Joint Canadian Cardiovascular Society–Canadian Thoracic Society statement outlines current approach to diagnosis and management of pulmonary hypertension First Canadian guidance document on management of syncope Canadian Cardiovascular Society issues first clinical practice guideline on assessment and management of syncope New evidence supports prescribing statins for primary prevention of CVD in the elderly New statin use lowers risk of all-cause and CV mortality in US veterans (75+ years) without atherosclerotic CVD at baseline First Previous 32 33 34 35 36 Next Last
